Axel Schumacher

Over 10 years documented track record as principal investigator and medical manager in an academic, clinical and pharmaceutical environment. Areas of expertise include epigenetic mechanisms of complex disorders (i.e. Alzheimer’s, Diabetes, Schizophrenia, Cancer), biomarker discovery & biobanking, SOP development, among others. Managed international R&D and marketing programs across Europe and North-America. Scientific coordinator for several multi-million $ projects with verifiable year-after-year success in achieving research & business goals. Extensive background in international, multicultural environments. My goal: Disruptive Innovation - Finding Pharma’s “Complete Solution”. Pharma & the Food industry have to get more customer-centric, redefining themselves in the condition management and disease prevention business. Using Big Data - Multi-Omics approaches, Pharma has to innovate now in patient relationship management, precision medicine, personalized prevention, epigenetics, mobile app/biometric device integration and life-style businesses, such as nutraceuticals. This is what I call "P5 medicine": Precise, Predictive, Preventive, Personalized & Participatory. It will change our world completely and is not a passing fad that will go away so easily....